Skip to main content

Zioptan FDA Approval History

FDA Approved: Yes (First approved February 10, 2012)
Brand name: Zioptan
Generic name: tafluprost
Dosage form: Ophthalmic Solution
Company: Merck & Co., Inc.
Treatment for: Glaucoma, Open Angle, Intraocular Hypertension

Zioptan (tafluprost ophthalmic solution) is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Development timeline for Zioptan

Feb 13, 2012Approval FDA Approves Zioptan (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication
Mar  9, 2011Merck Announces FDA Acceptance of New Drug Application for Investigational Ophthalmic Medication Saflutan (tafluprost)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.